In vitro analysis of tantalum-containing mesoporous bioactive glass fibres for haemostasis

被引:0
|
作者
Nagrath M. [1 ,2 ]
Rahimnejad Yazdi A. [3 ]
Marx D. [1 ,2 ]
Ni T. [4 ,5 ]
Gallant R.C. [4 ]
Ni H. [4 ,5 ,6 ]
Towler M.R. [7 ]
机构
[1] Biomedical Engineering, Faculty of Engineering and Architectural Science (FEAS), Ryerson University, Toronto, ON
[2] Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, ON
[3] Institutional Planning and Analysis, Humber College, Etobicoke, ON
[4] Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, ON
[5] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON
[6] Canadian Blood Services Centre for Innovation, Toronto, ON
[7] Doshi Professor of Chemical and Biochemical Engineering, Missouri University of Science and Technology, Rolla, MO
来源
关键词
Bioactive glasses; bleeding; haemostasis; mesoporous bioactive glasses;
D O I
10.1080/03091902.2024.2356618
中图分类号
学科分类号
摘要
Haemorrhage is the leading cause of battlefield deaths and second most common cause for civilian mortality worldwide. Biomaterials-based haemostatic agents are used to aid in bleeding stoppage; mesoporous bioactive glasses (MBGs) are candidates for haemostasis. Previously made Tantalum-containing MBG (Ta-MBG) powders’ compositions were fabricated as electrospun fibres for haemostatic applications in the present study. The fibres were fabricated to address the challenges associated with the powder form: difficult to compress without gauze, getting washed away in profuse bleeding, generating dust in the surgical environment, and forming thick callus-difficult to remove for surgeons and painful for patients. Ta-MBGs were based on (80-x)SiO2-15CaO-5P2O5-xTa2O5 mol% compositions with x = 0 (0Ta), 0.5 (0.5Ta), 1 (1Ta), and 5 (5Ta) mol%. The present study details the fibres’ in vitro analyses, elucidating their cytotoxic effects, and haemostatic capabilities and relating these observations to fibre chemistry and previously fabricated powders of the same glasses. As expected, when Ta addition is increased at the expense of silica, a new FTIR peak (non-bridging oxygen-silicon, Si-NBO) develops and Si-O-Si peaks become wider. Compared to 0Ta and 1Ta fibres, 0.5Ta show Si-O peaks with reduced intensity. The fibres had a weaker intensity of Si-NBO peaks and release fewer ions than powders. A reduced ion profile provides fibres with a stable matrix for clot formation. The ion release profile for 1Ta and 5Ta fibres was significantly lower than 0Ta and 0.5Ta fibres. Ta-MBGs were not found to be cytotoxic to primary rat fibroblasts using a methyl thiazolyl tetrazolium (MTT) assay. Furthermore, a modified activated partial thromboplastin time assay analysing the fibrin absorbance showed that the absorption increases from physiological clotting < 0Ta < 0.5Ta < 5Ta < commercial haemostat, Surgical SNoWTM, Ethicon, USA < 1Ta. Higher absorption signifies a stronger clot. It is concluded that Ta-MBG fibres can provide stable matrix for clot formation and 1Ta can potentially enhance clotting best among other Ta-MBGs. © 2024 Informa UK Limited, trading as Taylor & Francis Group.
引用
收藏
页码:12 / 24
页数:12
相关论文
共 50 条
  • [1] Tantalum-containing mesoporous bioactive glass powder for hemostasis
    Nagrath, Malvika
    Gallant, Reid
    Yazdi, Alireza Rahimnejad
    Mendonca, Andrew
    Rahman, Saidur
    Chiu, Loraine
    Ni, Heyu
    Towler, Mark R.
    JOURNAL OF BIOMATERIALS APPLICATIONS, 2021, 35 (08) : 924 - 932
  • [2] Tantalum-containing meso-porous glass fibres for hemostatic applications
    Nagrath, Malvika
    Yazdi, Alireza Rahimnejad
    Rafferty, Aran
    Daly, Dermot
    Rahman, Saeed Ur
    Gallant, Reid C.
    Ni, Heyu
    Arany, Praveen R.
    Towler, Mark R.
    MATERIALS TODAY COMMUNICATIONS, 2021, 27
  • [3] Porcine liver injury model to assess tantalum-containing bioactive glass powders for hemostasis
    Malvika Nagrath
    Danielle Bince
    Corwyn Rowsell
    Deanna Polintan
    Joao Rezende-Neto
    Mark Towler
    Journal of Materials Science: Materials in Medicine, 33
  • [4] Porcine liver injury model to assess tantalum-containing bioactive glass powders for hemostasis
    Nagrath, Malvika
    Bince, Danielle
    Rowsell, Corwyn
    Polintan, Deanna
    Rezende-Neto, Joao
    Towler, Mark
    JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2022, 33 (06)
  • [5] Europium-Containing Mesoporous Bioactive Glass Scaffolds for Stimulating in Vitro and in Vivo Osteogenesis
    Wu, Chengtie
    Xia, Lunguo
    Han, Pingping
    Mao, Lixia
    Wang, Jiacheng
    Zhai, Dong
    Fang, Bing
    Chang, Jiang
    Xiao, Yin
    ACS APPLIED MATERIALS & INTERFACES, 2016, 8 (18) : 11342 - 11354
  • [6] QUANTITATIVE XPS-ANALYSIS OF TANTALUM-CONTAINING AMORPHOUS-CARBON FILMS
    GRISCHKE, M
    BRAUER, A
    BENNDORF, C
    THIEME, F
    WILLICH, P
    FRESENIUS ZEITSCHRIFT FUR ANALYTISCHE CHEMIE, 1989, 333 (4-5): : 299 - 303
  • [7] A tantalum-containing zirconium-based metallic glass with superior endosseous implant relevant properties
    Wu, Yunshu
    Wang, Feifei
    Huang, Yao
    Zheng, Fu
    Zeng, Yuhao
    Lu, Zhen
    Wang, Songlin
    Sun, Baoan
    Sun, Yuchun
    BIOACTIVE MATERIALS, 2024, 39 : 25 - 40
  • [8] Synthesis and in vitro bioactivity of mesoporous bioactive glass scaffolds
    Shih, C. J.
    Chen, H. T.
    Huang, L. F.
    Lu, P. S.
    Chang, H. F.
    Chang, I. L.
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2010, 30 (05): : 657 - 663
  • [9] Preparation of tantalum-containing coatings on NiTi shape memory alloys with enhanced in vitro cytocompatibility and antibacterial effectiveness
    Soltanalipour, Mahdiyeh
    Khalil-Allafi, Jafar
    JOURNAL OF MATERIALS RESEARCH AND TECHNOLOGY-JMR&T, 2024, 30 : 8419 - 8432
  • [10] Mesoporous Bioactive Glass Promoted Osteoblast Proliferation and Differentiation In Vitro
    Chen, Jianwei
    Yu, Xiaosheng
    Ji, Hao
    Zong, Zhen
    Hong, Wei
    Zhong, Guibin
    Li, Zhanchun
    Guo, Fangwei
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2019, 9 (04) : 462 - 467